
From
Caijing Online Rio
Tinto stock dropped up to 4.7 percent Friday before closing at AU$ 51, or a 1.9
percent decline, following its announcement Thursday that the Australian mining
giant will receive a US$ 19.5 billion
cash
infusion from Aluminum Corporation of China. According
to the terms of the deal, China’s leading aluminum producer, known as
Chinalco,
will
invest US$ 7.2 billion in convertible bonds and US$ 12.3 billion in iron-ore,
copper and aluminum joint ventures with Rio Tinto. The deal will enable Chinalco
to increase its stake in Rio Tinto to 18
percent
and seat two members on Australian company’s board. Rio
Tinto Chief Executive Officer Tom Albanese said
on
a
conference call
Thursday that this valuation represents the best value to shareholders. Past
offers, such as a US$ 66 billion bid from Australian mining rival
BHP
Billiton,
did not meet preconditions and were never presented to shareholders,
he
said. Rio
Tinto’s chair-elect Jim Leng opposed the deal in favor of a rights issue and
resigned from his post on Sunday. Addressing
his rumored departure from the Chinese company, Chinalco general manager Xiao
Yaqing said, “The decision to enter into the strategic partnership was one made
by the entire executive board. Therefore, we do not believe that any human
resource shifts will negatively affect the
deal.” The
deal is still pending approval from the Australian and Chinese governments as
well as from Rio Tinto’s shareholders. If the transaction is successful, it will
become the largest overseas investment made by a Chinese
enterprise. Analysts
are divided on the value of the
deal. Acknowledging
that Rio Tinto may see lower pre-tax earnings and a weakened competitive
standing, Barclay Capital analysts wrote in a report
that
“the key credit story for Rio Tinto has been the company’s liquidity and
refinancing risk.” The cash infusion from Chinalco will go towards putting down
the world’s third-largest mining company’s debt of US$ 38
billion. Citi
analysts maintained its buy rating on the iron-ore company, saying that “the
Chinalco package at a premium to net-present value (NPV)
in
a difficult environment is preferable to discounted assets sales and/or rights
issue.”
Goldman
Sachs JBWere analysts, in contrast, were
negative. “We
don’t like this deal and don’t think it is the best option,” they said in a note
to clients. “Even with a cash injection of US$ 19.5 billion, Rio is still in a
weak position in terms of its balance sheet and would be unable to easily
participate in expansions, acquisitions or increased dividend payments for some
time.”

By intern reporter Shao
Lige.